In this study, we demonstrated that naringenin administration significantly alleviated collagen-induced RA chronic pain, via (i) suppressing the spinal central sensitization, (ii) limiting spinal microgliosis and astrogliosis and (iii) attenuating the expression of phosphorylated spinal CRMP2. The gene discussed is DPYSL2; the disease is rheumatoid arthritis.